- Home
- ETON vs YORW Comparison
ETON vs YORW Comparison
Compare ETON & YORW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ETON | YORW |
|---|---|---|
| Founded | 2017 | 1816 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.9M | 471.4M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ETON | YORW |
|---|---|---|
| Price | $16.70 | $32.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $29.67 | N/A |
| AVG Volume (30 Days) | ★ 216.1K | 72.0K |
| Earning Date | 03-17-2026 | 03-03-2026 |
| Dividend Yield | N/A | ★ 2.83% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.39 |
| Revenue | $70,316,000.00 | ★ $76,882,000.00 |
| Revenue This Year | $107.23 | $6.14 |
| Revenue Next Year | $29.72 | $7.69 |
| P/E Ratio | ★ N/A | $23.17 |
| Revenue Growth | ★ 102.77 | 3.63 |
| 52 Week Low | $11.09 | $29.68 |
| 52 Week High | $23.00 | $36.48 |
Technical Indicators
Market Signals| Indicator | ETON | YORW |
|---|---|---|
| Relative Strength Index (RSI) | 62.07 | 50.29 |
| Support Level | $14.49 | $31.33 |
| Resistance Level | $15.01 | $32.74 |
| Average True Range (ATR) | 0.64 | 0.72 |
| MACD | 0.19 | -0.09 |
| Stochastic Oscillator | 91.53 | 55.56 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About YORW York Water Company (The)
The York Water Co is an investor-owned water utility company in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. It also owns and operates three wastewater collection systems and eleven wastewater collection and treatment systems. The company operates within its franchised territory, which covers more than 57 municipalities within four counties in south-central Pennsylvania.